Search
EHA Statement on COVID-19
The European Hematology Association (EHA) closely monitors the latest developments on the spreading of the Coronavirus (COVID-19).
Read moreSurvey Monitoring H2020 – your input is needed!
We need your input to improve Horizon 2020 and the next Research and Innovation Framework Programme of the European Union.
Read moreEHA ‘Excellence in Hematology’ Survey now online
Excellence in Hematology is created together. Would you help us out?
This week, we’re starting an important research endeavor – our ‘Excellence in hematology’ survey.
Breakthrough results in European multicenter trial on acute promyelocytic leukemia (APL): no more chemotherapy?
APL is a rare, yet aggressive, subtype of acute myeloid leukemia (AML) characterized by a maturation arrest of white blood cell precursors in the marrow, leading to a shortage of normal white cells and platelets in the blood, which is…
Read moreHighlights from the SWG
EHA2023 CongressThe EHA2023 Congress was held in Frankfurt, Germany, in June 2023. Guideline sessionTitle‘The European Guidelines on Diagnosis and Management of Neutropenia in Adults and Children.
Read moreMeet Antonio Almeida, our February Volunteer of the Month
EHA is a Public Benefit Organization under Dutch law.
Read moreMeet Antonio Almeida, our February Volunteer of the Month
EHA is a Public Benefit Organization under Dutch law.
Read more